Showing results (11-20 of 406) with videos related to
Sort By:
Pageof 41
Deutsche Medizinische Wochenschrift (1946)|October 23, 2009
[56-year-old patient with leg paresis, pulmonary infiltrates, and eosinophilia--Case 08/2009]Jörg Henes, Marius Horger, Lothar Kanz, et al.Deutsche Medizinische Wochenschrift (1946)|March 6, 2018
[Follow-up Care in Cancer: Selected Solid Tumors and Hematological Neoplasias]Malte Rörden, Clemens Hinterleitner, Janina Metzger, et al.Annals of the New York Academy of Sciences|June 17, 2005
The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cellsGabriele Seitz, Andreas M Boehmler, Lothar Kanz, et al.Rheumatology International|December 17, 2009
Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritisJoerg Christoph Henes, Joerg Schedel, Lothar Kanz, et al.Journal of Cancer Research and Clinical Oncology|December 24, 2004
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantationWichard Vogel, Hans-Georg Kopp, Lothar Kanz, et al.Annals of the New York Academy of Sciences|June 12, 2003
Nonpeptide mediators in the hematopoietic microenvironmentRobert Mohle, Andreas M Boehmler, Claudio Denzlinger, et al.Blood|July 4, 2015
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapySimon Walz, Juliane S Stickel, Daniel Johannes Kowalewski, et al.Herpes : the Journal of the IHMF|February 28, 2002
CMV Infection in Bone Marrow and Solid Organ Transplant Patients in the Era of Antiviral ProphylaxisHolger Hebart, Gerhard Jahn, Christian Sinzger, et al.Leukemia & Lymphoma|October 21, 2005
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemiaStefan Knop, Ulrich Herrlinger, Ulrike Ernemann, et al.Annals of the New York Academy of Sciences|June 17, 2005
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cellsStefan Balabanov, Silke Appel, Lothar Kanz, et al.Pageof 41